Cite
HARVARD Citation
Strand, V. et al. (n.d.). FRI0144 Patient-reported outcomes with sarilumab in patients with rheumatoid arthritis are similar regardless of primary or secondary failure with tumour necrosis factor inhibitors. Annals of the rheumatic diseases. pp. 615-616. [Online].